0

Journal Articles

in Liver Disease
 21-40 of 109 Articles
Grand Rounds |  July 20, 2011
Hepatitis C Virus Infection and Coinfection With Human Immunodeficiency Virus:  Challenges and Advancements in Management
Colleen Hadigan, MD, MPH; Shyamasundaran Kottilil, MD, PhD
JAMA. 2011;306(3):294-301. doi:10.1001/jama.2011.975.
INCLUDES: CME
From the Centers for Disease Control and Prevention |  June 22, 2011 FREE
Hepatitis C Virus Infection Among Adolescents and Young Adults—Massachusetts, 2002-2009
JAMA. 2011;305(24):2511-2513. doi:.
Review |  June 01, 2011 FREE
Comparison of Effect Sizes Associated With Biomarkers Reported in Highly Cited Individual Articles and in Subsequent Meta-analyses
John P. A. Ioannidis, MD, DSc; Orestis A. Panagiotou, MD
JAMA. 2011;305(21):2200-2210. doi:10.1001/jama.2011.713.
INCLUDES: , Supplemental Content
Lab Reports |  June 01, 2011
Fatty Liver Disease
Tracy Hampton, PhD
JAMA. 2011;305(21):2162. doi:10.1001/jama.2011.724.
Original Contribution |  April 27, 2011 FREE
Effect of Vitamin E or Metformin for Treatment of Nonalcoholic Fatty Liver Disease in Children and Adolescents:  The TONIC Randomized Controlled Trial
Joel E. Lavine, MD, PhD; Jeffrey B. Schwimmer, MD; Mark L. Van Natta, MHS; et al.
JAMA. 2011;305(16):1659-1668. doi:10.1001/jama.2011.520.
INCLUDES: , Supplemental Content
Commentary |  March 16, 2011
Statistical Association and Causation:  Contributions of Different Types of Evidence
Charles H. Hennekens, MD, DrPH; David DeMets, PhD
JAMA. 2011;305(11):1134-1135. doi:10.1001/jama.2011.322.
Commentary |  November 17, 2010
Risk of Kava Hepatotoxicity and the FDA Consumer Advisory
Rolf Teschke, MD; Johannes Schulze, MD
JAMA. 2010;304(19):2174-2175. doi:10.1001/jama.2010.1689.
Preliminary Communication |  November 17, 2010 FREE
Doxorubicin Plus Sorafenib vs Doxorubicin Alone in Patients With Advanced Hepatocellular Carcinoma:  A Randomized Trial
Ghassan K. Abou-Alfa, MD; Philip Johnson, MD; Jennifer J. Knox, MD; et al.
JAMA. 2010;304(19):2154-2160. doi:10.1001/jama.2010.1672.
INCLUDES: , Supplemental Content
Lab Reports |  August 18, 2010
Growing Liver Grafts
Tracy Hampton, PhD
JAMA. 2010;304(7):733. doi:10.1001/jama.2010.1083.
Medical News & Perspectives |  June 23, 2010
Scant Attention to Pediatric Hepatitis C Means Most Children Are Left Behind
Rebecca Voelker
JAMA. 2010;303(24):2455-2456. doi:10.1001/jama.2010.830.
The World in Medicine |  June 16, 2010
Men and Liver Cancer
Joan Stephenson, PhD
JAMA. 2010;303(23):2346. doi:10.1001/jama.2010.797.
From the Centers for Disease Control and Prevention |  June 16, 2010 FREE
Hepatocellular Carcinoma—United States, 2001-2006
JAMA. 2010;303(23):2349-2350. doi:.
From the Centers for Disease Control and Prevention |  April 21, 2010 FREE
Severe Isoniazid-Associated Liver Injuries Among Persons Being Treated for Latent Tuberculosis Infection—United States, 2004-2008
JAMA. 2010;303(15):1471-1473. doi:.
Original Contribution |  March 17, 2010 FREE
Imaging Response in the Primary Index Lesion and Clinical Outcomes Following Transarterial Locoregional Therapy for Hepatocellular Carcinoma
Ahsun Riaz, MD; Frank H. Miller, MD; Laura M. Kulik, MD; et al.
JAMA. 2010;303(11):1062-1069. doi:10.1001/jama.2010.262.
INCLUDES: , Supplemental Content
Capitol Health Call |  December 09, 2009
Fighting Hepatitis
Mike Mitka
JAMA. 2009;302(22):2423. doi:10.1001/jama.2009.1805.
Preliminary Communication |  December 02, 2009 FREE
Association of Computed Tomography Morphologic Criteria With Pathologic Response and Survival in Patients Treated With Bevacizumab for Colorectal Liver Metastases
Yun Shin Chun, MD; Jean-Nicolas Vauthey, MD; Piyaporn Boonsirikamchai, MD; et al.
JAMA. 2009;302(21):2338-2344. doi:10.1001/jama.2009.1755.
The World in Medicine |  November 18, 2009
MicroRNA and Liver Cancer
Joan Stephenson, PhD
JAMA. 2009;302(19):2083. doi:10.1001/jama.2009.1682.
Medical News and Perspectives |  November 11, 2009
Silent Epidemic of Viral Hepatitis May Lead to Boom in Serious Liver Disease
Bridget M. Kuehn
JAMA. 2009;302(18):1949-1954. doi:10.1001/jama.2009.1588.
From the Centers for Disease Control and Prevention |  October 07, 2009 FREE
Hepatitis Temporally Associated With an Herbal Supplement Containing Artemisinin—Washington, 2008
JAMA. 2009;302(13):1412-1414. doi:.
Original Contribution |  September 09, 2009 FREE
Genetic Modifiers of Liver Disease in Cystic Fibrosis
Jaclyn R. Bartlett, PhD; Kenneth J. Friedman, PhD; Simon C. Ling, MB, ChB; et al.
JAMA. 2009;302(10):1076-1083. doi:10.1001/jama.2009.1295.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Original Article  |  May 8, 2013
Long-term Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases
Paul J. Karanicolas, MD, PhD; William R. Jarnagin, MD; Mithat Gonen, PhD; et al.
JAMA Surgery
Invited Critique  |  May 8, 2013
To Ablate or Not to Ablate?: That Is the Question:  Comment on “Tumor Ablation Outcomes Following Tumor Ablation for Treatment of Bilateral Colorectal Liver Metastases”
Karen L. Sherman, MD; David J. Bentrem, MD, MS
JAMA Internal Medicine
Challenges in Clinical Electrocardiography  |  April 22, 2013
Bizarre and Wide QRS After Liver Transplant
Colleen J. Johnson, MD, MS; Melvin A. Scheinman, MD; Mintu P. Turakhia, MD, MAS
JAMA Internal Medicine
Challenges in Clinical Electrocardiography  |  April 22, 2013
Bizarre and Wide QRS After Liver Transplant—Discussion
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems